作者
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, Arnab Chakravarti, Mark R Gilbert, Geoffrey R Barger, Stephen Coons, Peter Ricci, Dennis Bullard, Paul D Brown, Keith Stelzer, David Brachman, John H Suh, Christopher J Schultz, Jean-Paul Bahary, Barbara J Fisher, Harold Kim, Albert D Murtha, Erica H Bell, Minhee Won, Minesh P Mehta, Walter J Curran Jr
发表日期
2016/4/7
期刊
New England Journal of Medicine
卷号
374
期号
14
页码范围
1344-1355
出版商
Massachusetts Medical Society
简介
Background
Grade 2 gliomas occur most commonly in young adults and cause progressive neurologic deterioration and premature death. Early results of this trial showed that treatment with procarbazine, lomustine (also called CCNU), and vincristine after radiation therapy at the time of initial diagnosis resulted in longer progression-free survival, but not overall survival, than radiation therapy alone. We now report the long-term results.
Methods
We included patients with grade 2 astrocytoma, oligoastrocytoma, or oligodendroglioma who were younger than 40 years of age and had undergone subtotal resection or biopsy or who were 40 years of age or older and had undergone biopsy or resection of any of the tumor. Patients were stratified according to age, histologic findings, Karnofsky performance-status score, and presence or absence of contrast enhancement on preoperative images. Patients were randomly …
引用总数
2016201720182019202020212022202320243512612916113113311410763
学术搜索中的文章
JC Buckner, EG Shaw, SL Pugh, A Chakravarti… - New England Journal of Medicine, 2016